Skip to content
AnalystLens

CME GROUP INC. 8-K Report, Financial Results (Feb 14, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed February 14, 2024
Period End
February 14, 2024
Security
CME
In the record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’17Nov ’17
  2. Leadership change8-K · Feb ’20Feb ’20
  3. Material agreement8-K · Apr ’22Apr ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed February 14, 2024. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. (CME) has filed an 8-K report on February 14, 2024, primarily announcing its financial results for the quarter ended December 31, 2023.

The filing incorporates by reference a press release (Exhibit 99.1) which details these results. Investors should note that this press release includes non-GAAP financial measures, such as non-GAAP net income and earnings per share, alongside their GAAP counterparts. Management asserts that these non-GAAP measures offer valuable supplemental information for understanding financial and business trends, facilitating better comparability with prior periods.

While these non-GAAP figures are presented to provide a more comprehensive view, they should be considered in conjunction with, and not as a replacement for, the official GAAP financial statements. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is provided within the press release, adhering to Regulation G requirements.

Key Highlights

  1. CME Group Inc. reported its financial results for the fourth quarter of 2023 on February 14, 2024.
  2. The 8-K filing includes a press release (Exhibit 99.1) containing the detailed financial results.
  3. The press release presents both GAAP and non-GAAP financial measures, including non-GAAP net income and earnings per share.
  4. Management believes non-GAAP measures provide important supplemental information and enhance comparability.
  5. Reconciliation between non-GAAP and GAAP financial measures is provided in the press release as required by Regulation G.
  6. The filing itself does not contain new financial statements but references an attached press release.

Frequently Asked Questions

  1. What is the main purpose of this 8-K filing?

    The main purpose of this 8-K filing is to announce and provide CME Group Inc.'s financial results for the quarter ended December 31, 2023, through an attached press release.

  2. What are non-GAAP financial measures and why does CME Group use them?

    Non-GAAP financial measures, such as non-GAAP net income and earnings per share, are financial metrics that exclude or adjust items from their corresponding GAAP (Generally Accepted Accounting Principles) measures. CME Group uses them because management believes they provide important supplemental information about financial trends and improve comparability with prior periods, offering a potentially clearer view of operational performance.

  3. Are the non-GAAP measures presented in the press release the official financial results?

    No, the non-GAAP measures are supplemental and should be considered alongside the official GAAP financial statements. The press release includes a reconciliation to show how the non-GAAP figures relate to the GAAP figures.

  4. Where can I find the detailed financial results?

    The detailed financial results are provided in the press release attached to the 8-K filing as Exhibit 99.1.